Aigen Investment Management, LP Denali Therapeutics Inc. Transaction History

Aigen Investment Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $457,911 - $645,818	19,594 New	19,594 $578,000
Q4 2022 Feb 10, 2023	BUY	$26.28 - $33.92 $282,536 - $364,673	10,751 New	10,751 $298,000
Q3 2021 Nov 12, 2021	SELL	$48.48 - $78.23 $157,220 - $253,699	-3,243 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$50.3 - $78.44 $16,196 - $25,257	-322 Reduced 9.03%	3,243 $254,000
Q1 2021 May 11, 2021	BUY	$53.8 - $81.53 $191,797 - $290,654	3,565 New	3,565 $204,000
Q4 2020 Feb 12, 2021	SELL	$36.89 - $93.56 $475,032 - $1.2 Million	-12,877 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$23.13 - $38.84 $297,845 - $500,142	12,877 New	12,877 $461,000
Q1 2020 May 08, 2020	SELL	$14.2 - $27.98 $42,344 - $83,436	-2,982 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$14.4 - $19.99 $42,940 - $59,610	2,982 New	2,982 $52,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.